These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 22673053)

  • 1. Quieting the overactive hippocampus restores memory in aging.
    Baxter MG
    Trends Cogn Sci; 2012 Jul; 16(7):360-1. PubMed ID: 22673053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response of the medial temporal lobe network in amnestic mild cognitive impairment to therapeutic intervention assessed by fMRI and memory task performance.
    Bakker A; Albert MS; Krauss G; Speck CL; Gallagher M
    Neuroimage Clin; 2015; 7():688-98. PubMed ID: 25844322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment.
    Bakker A; Krauss GL; Albert MS; Speck CL; Jones LR; Stark CE; Yassa MA; Bassett SS; Shelton AL; Gallagher M
    Neuron; 2012 May; 74(3):467-74. PubMed ID: 22578498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of levetiracetam on visual-spatial memory following status epilepticus.
    Zhou JL; Zhao Q; Holmes GL
    Epilepsy Res; 2007 Jan; 73(1):65-74. PubMed ID: 17029741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of levetiracetam, an antiepileptic drug, on memory impairments associated with aging and Alzheimer's disease in mice.
    Devi L; Ohno M
    Neurobiol Learn Mem; 2013 May; 102():7-11. PubMed ID: 23416036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heightened cortical excitability in aged rodents with memory impairment.
    Haberman RP; Koh MT; Gallagher M
    Neurobiol Aging; 2017 Jun; 54():144-151. PubMed ID: 28104309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Piracetam and levetiracetam: close structural similarities but different pharmacological and clinical profiles.
    Genton P; Van Vleymen B
    Epileptic Disord; 2000 Jun; 2(2):99-105. PubMed ID: 10954241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment strategies targeting excess hippocampal activity benefit aged rats with cognitive impairment.
    Koh MT; Haberman RP; Foti S; McCown TJ; Gallagher M
    Neuropsychopharmacology; 2010 Mar; 35(4):1016-25. PubMed ID: 20032967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The place of levetiracetam in the treatment of epilepsy.
    Leppik IE
    Epilepsia; 2001; 42 Suppl 4():44-5. PubMed ID: 11564126
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of levetiracetam in the treatment of epilepsy.
    Brodie MJ; French JA
    Epileptic Disord; 2003 May; 5 Suppl 1():S65-72. PubMed ID: 12915344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive effects of piracetam in adults with memory impairment: A systematic review and meta-analysis.
    Gouhie FA; Barbosa KO; Cruz ABR; Wellichan MM; Zampolli TM
    Clin Neurol Neurosurg; 2024 Aug; 243():108358. PubMed ID: 38878641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacological treatment strategies targeting cognitive impairment associated with aging].
    Koh MT
    Nihon Yakurigaku Zasshi; 2012 Apr; 139(4):157-9. PubMed ID: 22498679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Convolvulus pluricaulis Choisy and Asparagus racemosus Willd on learning and memory in young and old mice: a comparative evaluation.
    Sharma K; Bhatnagar M; Kulkarni SK
    Indian J Exp Biol; 2010 May; 48(5):479-85. PubMed ID: 20795365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antiepileptic drug levetiracetam stabilizes the human epileptic GABAA receptors upon repetitive activation.
    Palma E; Ragozzino D; Di Angelantonio S; Mascia A; Maiolino F; Manfredi M; Cantore G; Esposito V; Di Gennaro G; Quarato P; Miledi R; Eusebi F
    Epilepsia; 2007 Oct; 48(10):1842-9. PubMed ID: 17521347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of hippocampal sclerosis in antiepileptic drug-related depression in patients with epilepsy: a study on levetiracetam.
    Mula M; Sander JW; Trimble MR
    Seizure; 2006 Sep; 15(6):405-8. PubMed ID: 16809055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with levetiracetam improves cognition in a ketamine rat model of schizophrenia.
    Koh MT; Shao Y; Rosenzweig-Lipson S; Gallagher M
    Schizophr Res; 2018 Mar; 193():119-125. PubMed ID: 28634087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omega 3 polyunsaturated fatty acids enhance the protective effect of levetiracetam against seizures, cognitive impairment and hippocampal oxidative DNA damage in young kindled rats.
    Abdel-Wahab BA; Shaikh IA; Khateeb MM; Habeeb SM
    Pharmacol Biochem Behav; 2015 Aug; 135():105-13. PubMed ID: 26044965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levetiracetam clinical pharmacokinetics in elderly and very elderly patients with epilepsy.
    Contin M; Mohamed S; Albani F; Riva R; Baruzzi A
    Epilepsy Res; 2012 Feb; 98(2-3):130-4. PubMed ID: 21944894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of levetiracetam on spike and wave discharges in WAG/Rij rats.
    Bouwman BM; van Rijn CM
    Seizure; 2004 Dec; 13(8):591-4. PubMed ID: 15519920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effect of levetiracetam on hippocampal sclerosis-like change in spontaneously epileptic rats.
    Sugata S; Hanaya R; Kumafuji K; Tokudome M; Serikawa T; Kurisu K; Arita K; Sasa M
    Brain Res Bull; 2011 Aug; 86(1-2):36-41. PubMed ID: 21669259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.